Biotech Specialty Pharma

Cytori Therapeutics

3020 Callan Road
San Diego, CA 92121 USA
Phone
Fax
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Medical technologies for regenerative medicine.

Management Christopher J. Calhoun, Chief Executive Officer; Marc H. Hedrick, M.D., President; Mark E. Saad, Chief Financial Officer; Douglas Arm, Ph.D., Vice President; Kenneth K. Kleinhenz, Vice President; Alexander M. Milstein, M.D., Vice President; Bruce Reuter, Senior Vice President; Seijiro N. Shirahama, President

Click here for Financial Data
Keywords: regenerative medicine, cosmetic, reconstructive, cardiovascular, disease, wound healing

Comment


Updated: Oct. 15, 2014


Description

Cytori Therapeutics, Inc. has actualized cutting edge regenerative medicine technology for the treatment of serious medical conditions. The company's proprietary technology, termed Celution System, ......view more

Products / Services

The principal products of Cytori Therapeutics include the Celution System family of products. These products processes patients' cells at the bedside in real time. Each member of the Celution System f......view more

Technology / Differentiation

Cytori Therapeutics goal is to provide access to clinical grade Adipose-Derived Stem and Regenerative Cells (ADRCs). ADRCs, sometimes referred to as stromal vascular fraction cells, are a heterogeneou...view more

Market / Customers

Green Hospital Supply is responsible for all sales and marketing while Cytori is responsible for manufacturing the Celution 900/MB System and sourcing all necessary equipment.......view more


Competitors / Substitutes / Alternatives

Aastrom Biosciences, Inc., Baxter International Inc., Osiris Therapeutics, Inc....view more

Status

As of March 28, 2013, the Company received US Patent No. 8,404,229 (the 229 patent) for methods of treating renal diseases using adipose-derived regenerative cells (ADRCs). The 229 patent cover...view more

RELATED COMPANIES



0000-00-00-16137